- Home
- ORLA vs RARE Comparison
ORLA vs RARE Comparison
Compare ORLA & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORLA
- RARE
- Stock Information
- Founded
- ORLA 2007
- RARE 2010
- Country
- ORLA Canada
- RARE United States
- Employees
- ORLA N/A
- RARE N/A
- Industry
- ORLA Precious Metals
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- ORLA Basic Materials
- RARE Health Care
- Exchange
- ORLA Nasdaq
- RARE Nasdaq
- Market Cap
- ORLA 3.1B
- RARE 3.2B
- IPO Year
- ORLA N/A
- RARE 2014
- Fundamental
- Price
- ORLA $12.14
- RARE $33.43
- Analyst Decision
- ORLA Buy
- RARE Strong Buy
- Analyst Count
- ORLA 1
- RARE 15
- Target Price
- ORLA $27.00
- RARE $87.00
- AVG Volume (30 Days)
- ORLA 2.2M
- RARE 1.4M
- Earning Date
- ORLA 11-11-2025
- RARE 11-04-2025
- Dividend Yield
- ORLA N/A
- RARE N/A
- EPS Growth
- ORLA N/A
- RARE N/A
- EPS
- ORLA 0.07
- RARE N/A
- Revenue
- ORLA $596,487,000.00
- RARE $630,598,000.00
- Revenue This Year
- ORLA $182.00
- RARE $19.65
- Revenue Next Year
- ORLA $38.17
- RARE $23.65
- P/E Ratio
- ORLA $142.53
- RARE N/A
- Revenue Growth
- ORLA 116.83
- RARE 20.63
- 52 Week Low
- ORLA $3.81
- RARE $25.81
- 52 Week High
- ORLA $13.91
- RARE $53.04
- Technical
- Relative Strength Index (RSI)
- ORLA 61.88
- RARE 54.15
- Support Level
- ORLA $9.45
- RARE $29.36
- Resistance Level
- ORLA $10.85
- RARE $35.95
- Average True Range (ATR)
- ORLA 0.53
- RARE 1.58
- MACD
- ORLA 0.12
- RARE -0.24
- Stochastic Oscillator
- ORLA 95.77
- RARE 65.40
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.